Protagenic Therapeutics, Inc.\new Adjustments to Additional Paid in Capital, Other
Protagenic Therapeutics, Inc.\new (PTIX) reported Adjustments to Additional Paid in Capital, Other of $410.76 thousand for the 12-month period ending 2025-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-14
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, other for the quarter ending 2024-06-30 was $319.76K.
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, other for fiscal 2025 was $410.76K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2025-03-31 | $410.76K 10-K · filed 2026-08-14 | |
| 2024-06-30 | $319.76K 10-Q · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |